Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2023) 92 PS2-18-05 | DOI: 10.1530/endoabs.92.PS2-18-05

ETA2023 Poster Presentations Treatment 1 (9 abstracts)

The first experience of laser interstitial thermotherapy in the treatment of patients with nodular goiter and cytology tbsrtc iv

Volodymyr Palamarchuk 1 , Oleksandr Tovkai 1 , Yelyzaveta Kozachuk 1 , Sergii Zemskov 2 , Nataliia Belemets 3 & Lyudmyla Stotska 4


1Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of Moh of Ukraine, Endocrine Surgery, Kyiv, Ukraine; 2Bogomolets National Medical University, Kyiv, Ukraine; 3Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of Moh of Ukraine, Cytology, Kyiv, Ukraine; 4Ukrainian Scientific and Practical Center of Endocrine Surgery, Transplantation of Endocrine Organs and Tissues of Moh of Ukraine, Ultrasound and Functional Diagnostics, Kyiv, Ukraine


The objective was to evaluate the short-term results of the laser interstitial thermotherapy (LITT) application in the treatment of patients with nodular goiter and cytology TBSRTC IV category.

Materials and methods: In 2021-2023, ultrasound-guided LITT was performed on 21 patients with nodular goiter and cytology TBSRTC IV. Laser type - GaAlAs Diode Laser (VELAS II-30F). The wavelength was 1064 nm, and the emission mode - continuous. Power at the 1st session was 3.4 (3.3; 3.5) W, at the 2nd - 3.4 (3.4; 3.45) W, P = 0.58. The energy at the 1st session was 510.0 (352.0; 784.5) J, the 2nd - 408 (258, 770.5) J, P = 0.31. Twenty-six LITT sessions were performed: Group I (n =12) - 1 session, Group II (n =6) - 2 sessions. Volume-reduction rate (VRR) and cytological smears at control TFNAB were evaluated. A positive result has been considered at VRR ± 70.0% and the absence of atypia in control smears. The average follow-up period was 4.0 (3.0; 6.3) months.

The results VRR after 1 LITT session ranged from 12.4% to 99.10%, after the 2nd LITT session at 1st control - min. - 85.7%, max. - 100.0%, at the 2nd control – 96.55%. The frequency of patients with VRR ± 70.0% in Group I was 75.0%, and in Group II – 100.0%, P = 0.52. Binary logistic regression analysis did not reveal a statistically significant relationship between the frequency of VRR ± 70.0% and the number of sessions or energy delivered to the node, P = 0.34. After LITT at control TFNAB in Group I, the frequency of TBSRTC IV was 20% (n =1), and TBSRTC II – 80.0% (n =4). In group II, TBSRTC IV – 40.0% (n =2), TBSRTC III – 40.0% (n =2), and TBSRTC II – 20.0% (n =1). The study groups did not differ statistically significantly in the frequency of TBSRTC II, III, and IV after LITT, P = 0.13. The average values of DAP-IV activity before LITT in patients of Group I was 6.0 (3.25, 8.0), after LITT – 0.0 (0.0, 3.5), P = 0.068. In Group II, DAP-IV before LITT was 0.0 (0.0; 6.5), and after LITT – 3.0 (1.5; 6.0), P = 0.581.

Conclusions: Laser interstitial thermotherapy can be an effective method of treatment for patients with nodular goiter and a cytology TBSRTC IV. However, to obtain more valid results, a study should be conducted on a larger sample. The research proceeds.

Volume 92

45th Annual Meeting of the European Thyroid Association (ETA) 2023

European Thyroid Association 

Browse other volumes

Article tools

My recent searches

No recent searches.